Cargando…

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017

During 2013–2017, 620 cases of Candida auris were reported in the European Union/European Economic Area – 466 (75.2%) colonisations, 110 (17.7%) bloodstream infections, 40 (6.5%) other infections and four cases (0.6%) of unknown colonisation/infection status – the majority from four large outbreaks....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohlenberg, Anke, Struelens, Marc J, Monnet, Dominique L, Plachouras, Diamantis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2018
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883451/ https://www.ncbi.nlm.nih.gov/pubmed/29616608 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.13.18-00136

Ejemplares similares

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020)

Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018
por: Brolund, Alma, et al.
Publicado: (2019)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019
por: Lötsch, Felix, et al.
Publicado: (2020)

Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area
por: Mårdh, Otilia, et al.
Publicado: (2023)

Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022
por: Linkevicius, Marius, et al.
Publicado: (2023)

Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018
por: Peñalva, Germán, et al.
Publicado: (2019)

Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
por: Kinross, Pete, et al.
Publicado: (2020)

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016
por: van Sighem, Ard, et al.
Publicado: (2017)

Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013
por: Kinross, Pete, et al.
Publicado: (2017)

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
por: Merk, Hanna, et al.
Publicado: (2019)

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
por: Cristea, Veronica, et al.
Publicado: (2023)

Consumption of cephalosporins in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Consumption of penicillins in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015
por: Pharris, Anastasia, et al.
Publicado: (2016)

Health crisis in Venezuela: Status of communicable diseases and implications for the European Union and European Economic Area, May 2019
por: Espinosa, Laura, et al.
Publicado: (2019)

Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020
por: Johnson, Helen C, et al.
Publicado: (2020)

Candida auris in Healthcare Facilities, New York, USA, 2013–2017
por: Adams, Eleanor, et al.
Publicado: (2018)

Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019
por: Stathi, Angeliki, et al.
Publicado: (2019)

Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Quality appraisal of antibiotic consumption in the community, European Union/European Economic Area, 2009 and 2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Cross-border spread of bla(NDM-1)- and bla(OXA-48)-positive Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019
por: Ludden, Catherine, et al.
Publicado: (2020)

Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021
por: Suetens, Carl, et al.
Publicado: (2021)

Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017: data collection, management and analysis
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Gender and organizational culture in the European Union: situation and prospects
por: Alonso Gallo, Nuria, et al.
Publicado: (2023)

The architecture of the European Union’s pandemic preparedness and response policy framework
por: Eerens, Dimitri, et al.
Publicado: (2022)

Mycobacterium chimaera infections associated with heater-cooler units (HCU): closing another loophole in patient safety
por: Struelens, Marc J., et al.
Publicado: (2016)

Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017
por: Currie, Jonny, et al.
Publicado: (2017)

Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012
por: Walter, Jan, et al.
Publicado: (2018)

First hospital outbreak of the globally emerging Candida auris in a European hospital
por: Schelenz, Silke, et al.
Publicado: (2016)

Beware of the commercialization of human cells and tissues: situation in the European Union
por: Pirnay, Jean-Paul, et al.
Publicado: (2012)

Art of Disaster Preparedness in European Union: a Survey on the Health Systems
por: Djalali, Ahmadreza, et al.
Publicado: (2014)

Securing circulation pharmaceutically: Antiviral stockpiling and pandemic preparedness in the European Union
por: Elbe, Stefan, et al.
Publicado: (2014)

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
por: Rondy, Marc, et al.
Publicado: (2018)

Isolation of Candida auris from invasive and non-invasive samples of a patient suffering from vascular disease, Italy, July 2019
por: Crea, Francesca, et al.
Publicado: (2019)

The 2017 European Union report on pesticide residues in food
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f6vnlenmbscddughp7ih8i1cqm